Marin J, Bourgoin P, Saverna N, Cartagena C, et al. The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab. Arthritis Res Ther 2025;27:86.
PMID: 40241223